Researchers have identified a potential new biomarker for cognitive decline associated with Alzheimer's disease. The study reports fibrinogen, a blood clotting protein, causes a series of molecular events that may trigger the destruction of connections between neurons, resulting in cognitive decline.
|
No comments:
Post a Comment